ArticleInternational journal of nanomedicine2018

Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.

Jean Christopher Chamcheu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.